Tekla Capital Management LLC
- SEC CIK
- 0001300336
- Latest filing
- Aug 10, 2023
ITCI holding history
Intra-Cellular Therapies, Inc. in every 13F filed by Tekla Capital Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ITCI overviewAll 13F holders of ITCIFull Q2 2023 holdings
- Shares (Q2 2023)
- 131,435
- Value
- $8.32M
- % of portfolio
- 0.3%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 131,435 | $8.32M | 0.3% | −40,936−23.7% | Reduced | Holders |
| Q1 2023 | 172,371 | $9.33M | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2022 | 172,371 | $9.12M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2022 | 172,371 | $8.02M | 0.3% | −71,066−29.2% | Reduced | Holders |
| Q2 2022 | 243,437 | $13.9M | 0.5% | −47,499−16.3% | Reduced | Holders |
| Q1 2022 | 290,936 | $17.8M | 0.6% | +54,489+23.0% | Added | Holders |
| Q4 2021 | 236,447 | $12.4M | 0.4% | −87,954−27.1% | Reduced | Holders |
| Q3 2021 | 324,401 | $12.1M | 0.4% | +121,645+60.0% | Added | Holders |
| Q2 2021 | 202,756 | $8.28M | 0.3% | −29,720−12.8% | Reduced | Holders |
| Q1 2021 | 232,476 | $7.89M | 0.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.